Overcoming Methodological Weakness in Dose-Intense Alkylating Agent Studies through Pharmacology

Roy B. Jones

doi:10.1158/1078-0432.CCR-1208-03

Overcoming Methodological Weakness in Dose-Intense Alkylating Agent Studies through Pharmacology

Roy B. Jones

Stem Cell Transplantation

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	413-414
Number of pages	2
Journal	Clinical Cancer Research
Volume	10
Issue number	2
DOIs	https://doi.org/10.1158/1078-0432.CCR-1208-03
State	Published - Jan 15 2004

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1158/1078-0432.CCR-1208-03

Cite this

@article{56afa65f380a46799942c1726941a858,

title = "Overcoming Methodological Weakness in Dose-Intense Alkylating Agent Studies through Pharmacology",

author = "Jones, {Roy B.}",

year = "2004",

month = jan,

day = "15",

doi = "10.1158/1078-0432.CCR-1208-03",

language = "English (US)",

volume = "10",

pages = "413--414",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "2",

}

TY - JOUR

T1 - Overcoming Methodological Weakness in Dose-Intense Alkylating Agent Studies through Pharmacology

AU - Jones, Roy B.

PY - 2004/1/15

Y1 - 2004/1/15

UR - http://www.scopus.com/inward/record.url?scp=0842290018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0842290018&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-1208-03

DO - 10.1158/1078-0432.CCR-1208-03

M3 - Editorial

C2 - 14760059

AN - SCOPUS:0842290018

SN - 1078-0432

VL - 10

SP - 413

EP - 414

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 2

ER -

Overcoming Methodological Weakness in Dose-Intense Alkylating Agent Studies through Pharmacology

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this